Title |
Self-monitoring and self-management of oral anticoagulation
|
---|---|
Published by |
John Wiley & Sons, Ltd, April 2010
|
DOI | 10.1002/14651858.cd003839.pub2 |
Pubmed ID | |
Authors |
Garcia-Alamino, Josep M, Ward, Alison M, Alonso-Coello, Pablo, Perera, Rafael, Bankhead, Clare, Fitzmaurice, David, Heneghan, Carl J |
Abstract |
The introduction of portable monitors (point-of-care devices) for the management of patients on oral anticoagulation allows self-testing by the patient at home. Patients who self-test can either adjust their medication according to a pre-determined dose-INR schedule (self-management) or they can call a clinic to be told the appropriate dose adjustment (self-monitoring). Several trials of self-monitoring of oral anticoagulant therapy suggest this may be equal to or better than standard monitoring. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 75% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 50% |
United Kingdom | 3 | 38% |
Denmark | 2 | 25% |
France | 1 | 13% |
Nigeria | 1 | 13% |
India | 1 | 13% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 22 | 275% |
Student > Master | 21 | 263% |
Student > Ph. D. Student | 13 | 163% |
Student > Bachelor | 10 | 125% |
Other | 8 | 100% |
Other | 24 | 300% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 69 | 863% |
Nursing and Health Professions | 7 | 88% |
Psychology | 5 | 63% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 25% |
Computer Science | 2 | 25% |
Other | 10 | 125% |